Sponsored
Haemophilia Treatment Market Set to Reach USD 28.44 Billion by 2032: Key Trends and Insights
Haemophilia is a rare, inherited bleeding disorder in which the blood does not clot properly, primarily due to a deficiency in clotting factors like Factor VIII (Haemophilia A) or Factor IX (Haemophilia B). This leads to prolonged bleeding episodes, either spontaneously or from injury. Globally, haemophilia affects approximately 1 in 5,000 male births, and while it is more common in men, it can...
0 Comments 0 Shares 2K Views 0 Reviews
Sponsored
Sponsored
Sponsored
google-site-verification: google037b30823fc02426.html